Pharmacy Perspectives for Tailoring Hemophilia A Prophylaxis: Current and Evolving Treatments

Join us for a live webinar on hemophilia A prophylaxis from the pharmacy perspective. You will gain insights from pharmacy Justin Arnall, PharmD, and Kayla Douglas, PharmD, on current and evolving treatments for hemophilia A and how to manage comorbidities in aging patients with hemophilia A.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

Agenda

7:00 – 7:10 PM Welcome and Introduction

7:10 – 7:30 PM Improving Clinical Outcomes With Factor Replacement Therapy – Justin Arnall, PharmD

7:30 – 7:50 PM Optimizing Nonfactor Therapy for Hemophilia A & Managing Comorbidities in Patients With Hemophilia as They AgeKayla Douglas, PharmD

7:50 – 8:00 PM Discussion and Audience Question and Answer Session

 

Events

Date / Time
Event Details

Faculty

Faculty
Justin Arnall, PharmD, BCOP

Faculty
Kayla Douglas, PharmD

Goal Statement
The goal of this activity is to educate pharmacists and managed care professionals about advances in the use of novel curative and noncurative therapeutic options for patients with hemophilia A.

Target Audience
This program is intended for pharmacists, managed care professionals, and other healthcare professionals who care for patients with hemophilia.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Implement individualized hemophilia A prophylaxis strategies that optimize adherence, outcomes, and utilization of resources
  • Identify patients who are likely to benefit from nonfactor replacement therapy
  • Mitigate complications and barriers to adherence in patients receiving factor replacement therapy
  • Apply recent safety and efficacy data for both factor replacement and nonfactor prophylaxis in hemophilia A to clinical practice
  • Manage comorbidities in patients receiving prophylaxis for hemophilia A
  • Develop a plan to educate the multidisciplinary team, patients, and caregivers on the characteristics, dosing, and administration of novel prophylaxis strategies

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Continuing Pharmacy Education

Designation of Credit

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number -JA4008176-0000-22-081-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.